Exploring the Real-life Stories of Individuals Enrolled in Lymphedema Clinical Trials

Status: Not_yet_recruiting
Location: See location...
Study Type: Observational
SUMMARY

The study intends to investigate the personal experiences of lymphedema patients who take part in a separate clinical trial including a specific medication intervention. The major focus will be on closely following individuals' rates of trial completion and withdrawal. The data collected from this study will help improve future outcomes for all lymphedema patients as well as those in under-represented demographic groups.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Patients diagnosed with lymphedema

• Aged ≥ 18 years old and ability to provide written informed consent obtained prior to participation in the study and any related procedures being performed

• Subjects willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examination.

Locations
United States
California
Power Life Sciences
San Francisco
Contact Information
Primary
Michael B Gill
bask@withpower.com
(415) 900-4227
Time Frame
Start Date: 2024-08
Completion Date: 2026-08
Participants
Target number of participants: 500
Related Therapeutic Areas
Sponsors
Leads: Power Life Sciences Inc.

This content was sourced from clinicaltrials.gov